Claims that the pharmaceutical company Merck hired ghostwriters for Vioxx articles has put heat on a U.S. proposal to loosen drug promotion rules.
The painkiller Vioxx was a top-selling drug before it was taken off the market in 2004 after clinical trials found it increased heart attack risks.
The report on Vioxx, published Wednesday by the Journal of the American Medical Association, brought questions to light regarding the accuracy of peer-reviewed medical research studies, The New York Times reported.
"What does it mean to be peer-reviewed if the company has essentially conceived the article, composed the draft and written the paper?" said Dr. Joseph S. Ross, author of the the JAMA article.
The FDA reportedly has taken a proposal into consideration that would allow drug companies to use peer-reviewed articles for the promotion of off-label drugs the administration has yet to approve.
Public Citizen, New York's state health commissioner and the Blue Cross Blue Shield Association have all said they oppose the FDA plan, the Times reported.
Copyright 2008 by United Press International
Related stories:
FDA pans Merck's new pain pill
The U.S. Food and Drug Administration has rejected Merck's bid to sell the pain medication Arcoxia in the United States.
Researchers target silicon chips for biomolecular devices
Arizona State University researchers in the Ira A. Fulton School of Engineering are key contributors to an $11.7 million, multicollaborative Defense Advanced Research Project Agency research project developing novel hybrid biomolecular nanodevices and systems for potential application as biosensors in areas such as disease detection, pharmaceutical drug-testing, drug-delivery systems and health monitoring.
States ask baby product companies to avoid BPA
(AP) -- Attorneys general from Connecticut, New Jersey and Delaware sent letters Friday to 11 companies that make baby bottles and baby formula containers, asking they no longer use the chemical bisphenol A in their manufacturing because they said it was potentially harmful to infants.
Limit on cold remedies for kids was FDA's idea
(AP) -- When drug makers made a surprise announcement this week that they no longer recommend cough and cold remedies for youngsters under 4, they didn't let on that it was the government's idea.
Want a mammogram? Get in line
Doctors usually recommend that women older than 40 get yearly mammograms. But if you're planning on calling Northwestern Memorial Hospital's state-of-the-art breast imaging center, grab next year's calendar: The next opening is in May.
Older renal cancer patients appear to benefit from sorafenib treatment
Older and younger patients with renal cancer derive similar benefit from sorafenib therapy and tolerate the drug equally well, according to a study published online October 7 in the
Journal of the National Cancer Institute.
Vietnam finds tainted products from China
(AP) -- Vietnam's health ministry has discovered the industrial chemical melamine in 18 food products imported from China and three other countries and has ordered them recalled and destroyed, officials said Friday.
FDA: No quick decision on cold medicines for kids
(AP) -- A top government health official rejected the idea of an immediate ban on cough and cold medicines for young children, saying it might cause unintended harm.